Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Bertolotto

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Current Opinion in Neurology|May 29, 2004
Neutralizing antibodies to interferon beta: implications for the management of multiple sclerosisAntonio Bertolotto
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 2015
Evaluation of the impact of neutralizing antibodies on IFNβ responseAntonio Bertolotto
Journal of the Neurological Sciences|February 10, 2009
Implications of neutralising antibodies on therapeutic efficacyAntonio Bertolotto
Neurology and Therapy|February 1, 2019
Neurology and Therapy: Looking Back on 2018 and Forward to 2019Marwan Sabbagh, Antonio Bertolotto
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Interferon-beta responders and non-responders. A biological approachAntonio Bertolotto, Francesca Gilli
Neurology|October 10, 2007
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyPer Soelberg Sorensen, Antonio Bertolotto
Journal of Neurology|July 21, 2004
Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosisFlorian Deisenhammer, Huub Schellekens, Antonio Bertolotto
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 22, 2010
Progressive multifocal leukoencephalopathy in Good's syndromeMarco Capobianco, Annalisa Pulizzi, Antonio Bertolotto
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2021
Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case reportMarco Capobianco, Antonio Bertolotto, Simona Malucchi
Neurology|November 12, 2003
Measurement of MxA mRNA or protein as a biomarker of IFNbeta bioactivity: detection of antibody-mediated decreased bioactivity (ADB)Andrew R Pachner, Antonio Bertolotto, Florian Deisenhammer
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Current Opinion in Neurology|May 29, 2004
Neutralizing antibodies to interferon beta: implications for the management of multiple sclerosisAntonio Bertolotto
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 2015
Evaluation of the impact of neutralizing antibodies on IFNβ responseAntonio Bertolotto
Journal of the Neurological Sciences|February 10, 2009
Implications of neutralising antibodies on therapeutic efficacyAntonio Bertolotto
Neurology and Therapy|February 1, 2019
Neurology and Therapy: Looking Back on 2018 and Forward to 2019Marwan Sabbagh, Antonio Bertolotto
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Interferon-beta responders and non-responders. A biological approachAntonio Bertolotto, Francesca Gilli
Neurology|October 10, 2007
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyPer Soelberg Sorensen, Antonio Bertolotto
Journal of Neurology|July 21, 2004
Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosisFlorian Deisenhammer, Huub Schellekens, Antonio Bertolotto
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 22, 2010
Progressive multifocal leukoencephalopathy in Good's syndromeMarco Capobianco, Annalisa Pulizzi, Antonio Bertolotto
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2021
Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case reportMarco Capobianco, Antonio Bertolotto, Simona Malucchi
Neurology|November 12, 2003
Measurement of MxA mRNA or protein as a biomarker of IFNbeta bioactivity: detection of antibody-mediated decreased bioactivity (ADB)Andrew R Pachner, Antonio Bertolotto, Florian Deisenhammer
Pageof 16